[ Price : $8.95]
FDA sets 5/23/23 as the target PDUFA action date for its review of ImmunityBios N-803 to treat some bladder cancers.[ Price : $8.95]
FDA accepts for review a Lexicon Pharmaceuticals NDA resubmission for sotagliflozin, an investigational dual SGLT1 and SGLT2 inhib...[ Price : $8.95]
Senate leaders introduce the Cannabis Administration and Opportunity Act.[ Price : $8.95]
FDA grants breakthrough therapy designation to Vertex VX-548 for some acute and neuropathic pain indications.[ Price : $8.95]
FDA warns Dr. Daniel Goodman about objectionable conditions in a clinical trial at his San Francisco, CA-based Goodman Eye Center.[ Price : $8.95]
FDA publishes a guidance to help drug sponsors who are planning to conduct clinical studies in neonatal populations.[ Price : $8.95]
FDA issues a draft guidance to help ensure that information is available to patients and health care professionals to clearly comm...[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of Ivax Pharmaceuticals ANDA for chloramphenicol capsules (250 mg) after the c...